Related by context. All words. (Click for frequent words.) 70 insulin detemir 70 dosing interval 70 bolus dose 70 dosage regimens 70 intravitreal injection 70 APTIVUS r 69 label dose titration 69 oral rivaroxaban 69 oral prednisone 68 dose escalation phase 68 #mg/day [002] 68 ropinirole 68 dose escalation 68 opioid analgesia 68 LATUDA 68 bolus injection 68 titration phase 68 intermittent dosing 67 salmeterol fluticasone 67 timepoints 67 subcutaneous injections 67 MIRCERA 67 APTIVUS 67 desvenlafaxine succinate 67 CIMZIA TM 67 AGILECT R 67 continuous intravenous infusion 67 titration 67 divalproex sodium 67 corticosteroid therapy 67 Dose escalation 67 active comparator 67 FOSRENOL ® 67 oral methylnaltrexone 67 PROMACTA 67 triamcinolone 66 KAPIDEX 66 tapentadol ER 66 β blockers 66 esomeprazole 66 tacrolimus ointment 66 dosing cohort 66 #mg/day [001] 66 mesalamine granules 66 IV bolus 66 riociguat 66 bupropion SR 66 systemic hypotension 66 dose cohort 66 NATRECOR ® 66 irbesartan 66 randomized #:#:# 66 BYSTOLIC 66 DAPT 66 subcutaneous infusion 66 anticoagulation therapy 66 dose regimens 66 BoNTA 66 blind placebo 66 dosing intervals 66 GnRH agonist 66 thorough QT 66 CIMZIA ™ 66 placebo controlled studies 66 Oral corticosteroids 66 biphasic insulin aspart 66 antihypertensive therapy 66 treprostinil 65 rotigotine 65 administered subcutaneously 65 corticosteroid dose 65 weekly subcutaneous injections 65 4mg/kg 65 oral anticoagulation 65 GAMMAGARD 65 lipid lowering therapy 65 atazanavir ritonavir 65 ibandronate 65 dosage regimen 65 #mg dose [001] 65 mg/m2 dose 65 guanfacine 65 ritonavir boosted 65 rFVIIa 65 #mg doses [002] 65 ACTEMRA TM 65 QT QTc 65 mesalazine 65 levodopa therapy 65 systemic corticosteroid 65 GLP1 agonist 65 ascending dose 65 liver biopsies 65 injected subcutaneously 65 tolvaptan 65 coadministration 65 PREZISTA r 65 alpha blocker 65 lanthanum carbonate 65 rt PA 65 gout flares 65 intradermal injections 65 formoterol fumarate 65 timepoint 65 oral antidiabetic medication 65 premedication 65 eosinophilic asthma 65 intravenous IV infusion 65 selegiline 65 dorzolamide 65 #mg dose [002] 64 visilizumab 64 nonrandomized 64 teriparatide 64 urate lowering therapy 64 fluticasone salmeterol 64 octreotide LAR 64 label titration 64 CHOP chemotherapy 64 LEXIVA r 64 Neupro R 64 ARIKACE 64 oral corticosteroids 64 RLAI 64 INVEGA ® 64 pyrazinamide 64 certolizumab 64 virological response 64 maximal dose 64 deferoxamine 64 HAART regimens 64 COREG 64 pyridostigmine 64 cinacalcet 64 eszopiclone 64 ERBITUX therapy 64 methylnaltrexone 64 mg kg dose 64 AZOR 64 elective PCI 64 pentoxifylline 64 detemir 64 EVIZON 64 Elitek 64 interferon beta 1b 64 abatacept 64 ribavirin RBV 64 μg kg 64 placebo controlled clinical trials 64 anagrelide 64 zonisamide SR 64 Lamictal XR 64 ropivacaine 64 alteplase 64 intra articular injection 64 solifenacin 64 FOSRENOL R 64 systemic corticosteroids 64 intramuscular injections 64 teriflunomide 64 amoxicillin clavulanate 64 Betaferon ® 64 USL# 64 ARB telmisartan 64 HAART regimen 64 deferasirox 64 postintervention 64 mcg BID 64 nebulization 64 corifollitropin alfa 64 VAPRISOL 64 ancrod 63 bezafibrate 63 statin monotherapy 63 MULTAQ 63 methotrexate therapy 63 double blinded placebo 63 intradermal injection 63 eptifibatide 63 nadolol 63 laxation 63 DMARD therapy 63 aplindore 63 bisphosphonate therapy 63 genotypic resistance 63 CYT# QbG# 63 MoxDuo TM IR 63 SCIg 63 thromboprophylaxis 63 paroxysmal AF 63 icatibant 63 ZOLINZA 63 multicenter randomized placebo controlled 63 oral corticosteroid 63 comparator arm 63 clomipramine 63 daily subcutaneous injections 63 maximal doses 63 ALT flares 63 intravenous cyclophosphamide 63 PRADAXA 63 RSD# oral 63 prucalopride 63 oral antidiabetes 63 piperacillin tazobactam 63 intravenous dosing 63 intravenous tPA 63 relapsed MM 63 lomitapide 63 intravenous methylnaltrexone 63 Traficet EN 63 citalopram hydrobromide 63 steroid dexamethasone 63 ATACAND 63 hour bronchodilation 63 postprocedure 63 trials RCTs 63 extubation 63 titrated 63 NATRECOR R 63 timolol 63 warfarin therapy 63 intravitreal injections 63 parathyroidectomy 63 zileuton 63 #mg BID [001] 63 lacosamide 63 aripiprazole 63 mg QD 63 flutamide 63 anakinra 63 placebo controlled 63 HCV RESPOND 2 63 interferon ribavirin 63 tirofiban 63 adalimumab 63 antibiotic prophylaxis 63 AZILECT R 63 abacavir lamivudine 63 AGILECT ® 63 tegaserod 63 ARCOXIA 63 pramipexole 63 zolmitriptan 63 flecainide 63 nab paclitaxel 62 FROVA 62 randomized multicenter trial 62 placebo controlled Phase 62 8mg/kg 62 ULORIC 62 virologic failure 62 hemoglobin A1c HbA1c 62 MoxDuo IR 62 chemoradiation therapy 62 Cladribine tablets 62 posttreatment 62 dosing cohorts 62 clopidogrel therapy 62 plasma glucose 62 Phe restricted diet 62 inhaled iloprost 62 tolterodine 62 electrical cardioversion 62 topical NSAIDs 62 telaprevir dosing 62 TNF alpha inhibitor 62 PEARL SC 62 pegaptanib 62 mcg kg 62 FASLODEX 62 APTIVUS ritonavir 62 Arikace 62 dose colchicine 62 concomitant medications 62 IFN alfa 62 #mg QD [001] 62 nicardipine 62 goserelin 62 KOMBIGLYZE XR 62 subcutaneously administered 62 cefazolin 62 antiarrhythmic 62 bronchodilation 62 edifoligide 62 ascending doses 62 randomized multicenter 62 capsule formulation 62 BENICAR HCT 62 Q#IR 62 triptorelin 62 intravenous bolus 62 LPV r 62 glatiramer acetate 62 dopaminergic therapy 62 olmesartan 62 oral prednisolone 62 blinded randomized 62 rasagiline 62 anticlotting drugs 62 CIMZIA R 62 uric acid lowering 62 NSAID therapy 62 glulisine 62 LANTUS R 62 glycemia 62 phase IIb trial 62 ALVESCO HFA 62 moderate renal impairment 62 mucosal healing 62 dosing 62 CorVue ™ 62 TREDAPTIVE 62 dosing regimen 62 antidiabetic medications 62 saline placebo 62 hypokalemia 62 subcutaneous SC 62 montelukast 62 RSD# 62 hemoglobin A1c levels 62 rFSH 62 lanreotide 62 vecuronium 62 phase IIIb 62 MVax 62 rtPA 62 severe exacerbations 62 nitrofurantoin 62 weekly intravenous infusions 62 zaleplon 62 placebo controlled trials 62 lamotrigine 62 Raptiva r 62 paricalcitol 62 prospectively stratified 62 stavudine d4T 62 AMEVIVE 62 doxorubicin docetaxel 62 #mg dose [003] 62 canakinumab 62 platelet inhibition 62 cilostazol 62 sufentanil 62 Insulin PH# 62 postoperative chemotherapy 62 dexmedetomidine 62 subcutaneous dosing 62 ketorolac 62 PASI scores 62 VIRAMUNE 62 multidose 62 methylprednisolone 62 PRISTIQ 62 insulin lispro 61 GnRH agonists 61 TDF FTC 61 Study GL# 61 morphometric vertebral fractures 61 ALA PDT 61 overt nephropathy 61 fibrinolysis 61 mg Pycnogenol 61 methotrexate monotherapy 61 QTc prolongation 61 MAS XR 61 REVLIMID lenalidomide 61 IOP lowering 61 ULTRAM ER 61 VA# [002] 61 induction regimen 61 pharmacokinetic parameters 61 antiarrhythmic drugs 61 OADs 61 IR prednisone 61 unblinded 61 baminercept 61 colesevelam HCl 61 glargine 61 indapamide 61 lactulose 61 inhaled budesonide 61 histrelin 61 epoetin alpha 61 pamidronate 61 PRADAXA #mg 61 posaconazole 61 STRIDE PD 61 severe renal impairment 61 paliperidone palmitate 61 ACAPODENE 61 CIMZIA TM certolizumab pegol 61 ocular inflammation 61 brivaracetam 61 eculizumab therapy 61 post operative ileus 61 Perforomist Inhalation Solution 61 Exforge HCT 61 rapid virologic response 61 randomized blinded 61 pharmacokinetic PK profile 61 enteric coated naproxen 61 hypocalcemia 61 CANCIDAS 61 PULMICORT RESPULES 61 basal insulin 61 olopatadine 61 amphotericin B 61 DCCT 61 intravesical 61 bronchial thermoplasty 61 interferon alfa 2b 61 CAELYX 61 Phase 2b study 61 tranylcypromine 61 paracentesis 61 sotalol 61 pouchitis 61 primary hypercholesterolemia 61 aromatase inhibitor therapy 61 relapsing MS 61 immunosuppressive regimen 61 DLTs 61 peginterferon 61 plasma uric acid 61 O PPDS 61 dose dose escalation 61 inhaled corticosteroids ICS 61 randomisation 61 EDARBI 61 trastuzumab Herceptin ® 61 HbA1c levels 61 olanzapine LAI 61 NovoLog ® Mix 61 lispro 61 forodesine 61 insulin glulisine 61 chemoradiotherapy 61 clevidipine 61 phase Ib 61 dexamethasone Decadron 61 aspartate aminotransferase AST 61 MIRAPEX 61 alvimopan 61 BRINAVESS 61 tocilizumab 61 antiarrhythmic drug 61 rHuEPO 61 hypomagnesemia 61 lenalidomide dexamethasone 61 spontaneous bowel movements 61 oxymorphone ER 61 dalteparin 61 ximelagatran 61 BRIM2 61 subcutaneous insulin 61 PrandiMet TM 61 drug eluting stent implantation 61 Protelos 61 Phase Ib study 61 INVEGA SUSTENNA 61 Phase #/#a 61 subcutaneous enoxaparin 61 BROVANA 61 intravenous morphine 61 platelet inhibitor 61 secondary efficacy endpoint 61 MBCT 61 virological failure 61 serum cortisol 61 insulin degludec 61 darunavir ritonavir 61 dosing regimens 61 antiretroviral regimen 61 FOLPI 61 adenotonsillectomy 61 microdose 61 Postoperatively 61 oral anticoagulant therapy 61 mitomycin C 61 randomized controlled clinical trials 61 RRMS patients 61 fluticasone furoate 61 plasma glucose levels 61 hematologic toxicity 61 subcutaneous PRO 61 remifentanil 61 peg IFN 61 LOVENOX R 61 tolterodine ER 61 pegnivacogin 61 pegylated interferon alfa 61 MYCAMINE 61 intravenous vancomycin 61 APRISO 61 dosing frequency 61 ORENCIA ® 61 EXJADE 61 tamoxifen therapy 61 HPA axis suppression 61 rEV# 61 oxybutynin 61 Zentase 61 oral levofloxacin 61 HuMax EGFr 61 ug kg 61 docetaxel chemotherapy 61 Hypotension 61 antihypertensive medications 61 stent implantation 61 levetiracetam 61 #mg QD [002] 61 Primary endpoints 61 GSK# [001] 61 FIRMAGON 61 budesonide foam 61 ginkgo extract 61 NPH insulin 61 leflunomide 61 fluvastatin 61 RLY# 61 double blinded randomized 61 ritonavir boosted protease inhibitor 61 glycosylated hemoglobin levels 61 HbA 1c levels 61 idraparinux 61 achieved statistical significance 61 nitazoxanide 61 FAMPYRA 61 xanthine oxidase inhibitor 60 azelastine 60 Pegasys plus Copegus 60 analgesic efficacy 60 hylan GF 60 maximally tolerated dose 60 inotropic therapy 60 efficacy endpoint 60 mCi kg 60 phase IIa 60 aspirin clopidogrel 60 ONTAK 60 hematological toxicity 60 octreotide 60 Dasatinib 60 glycated hemoglobin levels 60 lesinurad 60 sitaxsentan 60 VIIBRYD 60 aripiprazole Abilify 60 #mg/m# [002] 60 peak plasma concentrations 60 DCCR 60 antithrombotic therapy 60 beta blocker therapy 60 RezularTM 60 transaminase elevations 60 Gabapentin GR 60 ß blockers 60 #mg dosing 60 IBS C 60 EMSAM 60 mesalamine 60 symptomatic VTE 60 serum phosphate levels 60 azilsartan medoxomil 60 Insulin detemir 60 intravenous bisphosphonates 60 ethambutol 60 HBeAg seroconversion 60 TORISEL 60 mg dose 60 unblinding 60 hyperalgesia 60 carcinogenicity study 60 symptomatic paroxysmal AF 60 placebo controlled clinical 60 Keppra XR 60 NLX P# 60 Viread Emtriva 60 herpetic keratitis 60 posttransplant 60 Butrans 60 PEGINTRON TM 60 pulmonary artery banding 60 bupivacaine 60 ruboxistaurin 60 inotropes 60 valacyclovir 60 DVT prophylaxis 60 acetazolamide 60 prazosin 60 PRIMO CABG 60 Apidra ® 60 pharmacodynamics PD 60 adjunctive placebo 60 fondaparinux 60 ciclosporin 60 antiretroviral naive 60 androgen suppression 60 conjunctival hyperemia 60 Vimpat R 60 intrathecal chemotherapy 60 concurrent chemoradiation 60 corticosteroid dexamethasone 60 intravenous diuretics 60 mL kg 60 dose placebo controlled 60 GnRH antagonist 60 EMEND 60 QTcF 60 dopamine partial agonist 60 alicaforsen enema 60 glycated hemoglobin HbA1c 60 gadobutrol 60 clinical pharmacology studies 60 bolus doses 60 mitoxantrone 60 LYSTEDA 60 TYGACIL 60 mometasone furoate 60 oral antidiabetes drugs 60 anti coagulant therapy 60 oxycodone CR 60 QTc 60 gel formulation 60 pharmacokinetic interactions 60 PRECiSE 60 Tolvaptan 60 adalimumab Humira 60 ARIXTRA 60 AZILECT ® 60 BENICAR 60 calculated creatinine clearance 60 mealtime insulin 60 Twinrix 60 mg/m2/day 60 bisoprolol 60 ALGRX 60 evaluable subjects 60 reintubation 60 anticoagulant warfarin 60 efalizumab 60 GI motility 60 apremilast 60 dual antiplatelet therapy 60 ADVANCE PD 60 phase IIb 60 avosentan 60 cannabinor 60 5-FU/LV 60 lenalidomide Revlimid R 60 Lofexidine 60 insulin secretagogue 60 QVA# 60 decitabine 60 NAbs 60 lavage 60 opioid induced bowel dysfunction 60 odanacatib 60 pharmacodynamic effects 60 RAPAFLO 60 CPAP adherence 60 AVELOX 60 Prosaptide 60 alefacept 60 squalamine 60 biologic DMARD 60 trandolapril 60 vitamin B# folic acid 60 antihyperglycemic 60 antidepressant therapy 60 venlafaxine ER 60 masked placebo controlled 60 VIRAMUNE XR 60 tumor resection 60 angiotensin converting enzyme inhibitor 60 ribavirin therapy 60 aminotransferases 60 antiplatelet medication 60 Peg IFN 60 chemotherapy docetaxel 60 randomized Phase IIb 60 EGFRIs 60 TNF inhibitor 60 AZILECT 60 IFN beta 60 RAPAFLO R 60 mcg kg min 60 symptomatic hypotension 60 serum phosphorous 60 EFFEXOR XR 60 potent CYP#A# inhibitors 60 mg d 60 monoamine oxidase inhibitors MAOIs 60 aldosterone antagonists 60 infliximab 60 certolizumab pegol 60 release cysteamine bitartrate 60 EMBEDA TM 60 antiandrogen 60 serum phosphate 60 pregabalin 60 parathyroid hormone PTH 60 controlled analgesia PCA 60 carbidopa levodopa 60 transaminases 60 acute decompensation 60 guanfacine extended release 60 Capesaris 60 Xibrom TM 60 unfractionated heparin UFH 60 estramustine 60 viral kinetics 60 bowel resection 60 calcineurin inhibitor 60 serum phosphorus 60 eplerenone 60 Phase IIIb clinical 60 QTc intervals 60 hyperphenylalaninemia HPA due 60 subcutaneous ORENCIA 60 airway narrowing 60 iPTH 60 CUSTOM III 60 EUFLEXXA R 60 SIMCOR 60 CsA 60 multicenter placebo controlled 60 achieved ACR# 60 phase IIb clinical 60 chlorambucil 60 PegIFN RBV 60 antiplatelet agent 60 dose cyclophosphamide 60 hypoglycemic episodes 60 docetaxel Taxotere ® 60 suppressive therapy 60 subcutaneous dose 60 sequestered naltrexone 60 enalapril 60 dose proportionality 60 H2RAs 60 aprepitant 60 transdermal fentanyl 60 blinded randomized placebo controlled 60 phase IIb study 60 LCP AtorFen 60 mg eq 60 macroalbuminuria 60 mg/# hr 60 plasma pharmacokinetics 60 fenofibric acid 60 pioglitazone HCl 60 Veramyst 60 Advagraf 60 zalutumumab 60 Lucentis injections 60 TMP SMX 60 carbidopa 60 LMWH 60 levodopa carbidopa 60 BAL# [002] 60 transaminase levels 59 #mg/m# [001] 59 sublingual tablets 59 azacitidine 59 activator rt PA 59 TLK# 59 androgen ablation 59 placebo intravenously 59 caspofungin 59 mcg QD 59 edoxaban 59 Phase 2a trial 59 androgen blockade 59 tamsulosin 59 Alfimeprase 59 undetectable HBV DNA 59 clock opioid 59 dose regimen 59 rabeprazole 59 AeroLEF TM 59 JANUMET 59 glycoprotein IIb IIIa inhibitor 59 indiplon capsules 59 leukotriene receptor antagonist 59 esomeprazole Nexium 59 Adalimumab 59 ACTIVE W 59 Phase IIB 59 VFEND 59 adrenal suppression 59 peg interferon 59 nephrotoxicity 59 elagolix 59 Aptivus ® 59 INVEGA 59 prospective randomized placebo 59 Solulin 59 FFNS 59 Tekamlo 59 doxorubicin cyclophosphamide 59 MADIT II 59 MEVACOR 59 gastrointestinal toxicity 59 denervation 59 imatinib therapy 59 sub maximal 59 hepatic metabolism 59 cardiovascular calcification 59 pegylated interferon alfa 2b 59 mg BID 59 myopathy rhabdomyolysis 59 glomerular filtration 59 cholestyramine 59 Phase #b/#a trial 59 Pegylated Liposomal Doxorubicin 59 INTELENCE 59 metoprolol succinate 59 darunavir r 59 acute gout flares 59 fibrinolytic therapy 59 antiplatelet drugs 59 Helicobacter pylori eradication 59 q#h 59 Ophena TM 59 nelfinavir 59 warfarin sodium 59 XEPLION R 59 tenecteplase 59 ketoconazole 59 Itopride 59 ginkgo biloba extract 59 repaglinide 59 mg subcutaneously 59 moderate hepatic impairment 59 rHuPH# 59 anti androgen 59 mycophenolate mofetil 59 oral dosing 59 PA# [002] 59 dosed orally 59 Ventavis ® 59 HF ACTION 59 L thyroxine 59 Vagifem 59 antiepileptics 59 carotid endarterectomy CEA 59 immunomodulatory therapy 59 tramadol acetaminophen 59 clotrimazole 59 #.#g/day 59 prospective randomized multicenter 59 elotuzumab 59 heterozygous FH 59 rosuvastatin #mg 59 EDSS scores 59 colectomy 59 custirsen 59 ZOMIG Nasal Spray 59 peginterferon alfa 2b 59 NIASPAN 59 randomized 59 proton pump inhibitor PPI 59 hepatic insufficiency 59 titrate 59 DMARD 59 pretreatment baseline 59 topical diclofenac 59 COPD exacerbation 59 acyclovir Lauriad R 59 ganciclovir 59 antiemetics 59 urate lowering 59 oral iron chelator 59 d4T stavudine Zerit 59 bovine thrombin 59 allopurinol 59 anthracycline chemotherapy 59 COPAXONE R 59 colorectal liver metastases 59 DOXIL 59 Tarceva TM 59 REMINYL ® 59 voriconazole 59 rizatriptan 59 optimal dosing 59 tipranavir r 59 ISTODAX 59 Interferon alpha 59 urocortin 2 59 pramlintide metreleptin combination 59 peginterferon alfa 2a 59 rituximab Rituxan ® 59 multicenter randomized 59 dose escalation Phase 59 OROS ® 59 griseofulvin 59 pharmacodynamic profile 59 Eltrombopag 59 MAO inhibitors 59 pleurodesis 59 crossclamp 59 graft occlusion 59 virologic response 59 NUCYNTA R 59 Nebulized 59 Lantus R 59 Proellex TM 59 FLECTOR R Patch 59 RAPAMUNE 59 IBS symptoms 59 hemoptysis 59 cangrelor 59 adipiplon 59 COPAXONE ® 59 piroxicam 59 Neulasta ® 59 rilonacept 59 Vaprisol 59 multicenter Phase II 59 Diovan HCT 59 microgram kg 59 allergen immunotherapy 59 STELARA ™ 59 IIIa inhibitor 59 placebo controlled Phase III 59 acarbose 59 milrinone 59 mg orally 59 Zyclara 59 pimozide 59 injectable formulations 59 postoperative 59 ASSERT trial 59 concomitant antibiotics 59 sedating antihistamine 59 nadroparin 59 LEXIVA 59 lipid lowering agents 59 ablative therapy 59 metformin sulfonylurea 59 bronchoconstriction 59 tipranavir 59 coronary revascularization 59 SERCA2a 59 nifedipine 59 clinically meaningful improvement 59 pharmacokinetic characteristics 59 TOLAMBA 59 LEUKINE 59 REG1 59 sitagliptin 59 antimuscarinic 59 acting insulins 59 nephrotoxic drugs 59 nortriptyline 59 glucose tolerance test 59 HFA MDI 59 metformin HCl 59 atorvastatin #mg 59 trimethoprim sulfamethoxazole 59 Cimzia TM 59 upper gastrointestinal tract 59 antibiotic regimens 59 hsCRP levels 59 rhTSH 59 octreotide acetate 59 paliperidone 59 alkylating agent 59 tolevamer 59 primidone 59 FIRAZYR 59 abiraterone acetate 59 Pegasys ® 59 intensive lipid lowering 59 MAGE A3 ASCI 59 NovoMix ® 59 candesartan cilexetil 59 mcg dose 59 carvedilol 59 inhaled corticosteroid ICS 59 interferon therapy 59 budesonide formoterol 59 FRAGMIN R 59 phenelzine 59 antiangiogenic therapy 59 detectable HCV RNA 59 Desferal 59 NSTE ACS 59 peritumoral brain edema 59 tecarfarin 59 NOXAFIL 59 inotropic 59 L PPDS 59 vandetanib 59 oral dosing regimen 59 mg/m2 cohort 59 intravenous iv